177Lu-DOTATATE

You have access
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT)
Christopher E Wee, Ayca Dundar, Rachel A Eiring, Mohamed Badawy, Timothy J Hobday, Ayse Tuba Kendi, Annie T Packard and Thorvardur R. Halfdanarson

Journal of Nuclear Medicine March 19, 2021, jnumed.121.262048; DOI: https://doi.org/10.2967/jnumed.121.262048
You have access
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with ¹⁷⁷Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors
Rahul V Parghane, Manish Bhandare, Vikram Chaudhari, Shailesh V Shrikhande, Vikas Ostwal, Anant Ramaswamy, Sanjay Talole and Sandip Basu

Journal of Nuclear Medicine February 26, 2021, jnumed.120.258772; DOI: https://doi.org/10.2967/jnumed.120.258772
You have access
Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy
Jonathan R. Strosberg, Taymeyah Al-Toubah, Eleonora Pellè, Johnna Smith, Mintallah Haider, Tai Hutchinson, Jason B. Fleming and Ghassan El-Haddad

Journal of Nuclear Medicine January 1, 2021, 62 (1) 69-72; DOI: https://doi.org/10.2967/jnumed.120.242875
You have access
Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in ¹⁷⁷Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment
Luis David Jiménez-Franco, Gerhard Glatting, Vikas Prasad, Wolfgang A. Weber, Ambros J. Beer and Peter Kletting

Journal of Nuclear Medicine January 1, 2021, 62 (1) 92-98; DOI: https://doi.org/10.2967/jnumed.120.245068
You have access
In Vivo Instability of ¹⁷⁷Lu-DOTATATE During Peptide Receptor Radionuclide Therapy
Mark Lubberink, Helena Wilking, Amalia Öst, Ezgi Ilan, Mattias Sandström, Camilla Andersson, Katarzyna Fröss-Baron, Irina Velikyan and Anders Sundin

Journal of Nuclear Medicine September 1, 2020, 61 (9) 1337-1340; DOI: https://doi.org/10.2967/jnumed.119.237818
Open Access
Imaging DNA Damage Repair In Vivo After ¹⁷⁷Lu-DOTATATE Therapy
Edward O’Neill, Veerle Kersemans, P. Danny Allen, Samantha Y.A. Terry, Julia Baguña Torres, Michael Mosley, Sean Smart, Boon Quan Lee, Nadia Falzone, Katherine A. Vallis, Mark W. Konijnenberg, Marion de Jong, Julie Nonnekens and Bart Cornelissen

Journal of Nuclear Medicine May 1, 2020, 61 (5) 743-750; DOI: https://doi.org/10.2967/jnumed.119.232934
Open Access
Bone Marrow Absorbed Doses and Correlations with Hematologic Response During ¹⁷⁷Lu-DOTATATE Treatments Are Influenced by Image-Based Dosimetry Method and Presence of Skeletal Metastases
Linn Hagmarker, Johanna Svensson, Tobias Rydén, Martijn van Essen, Anna Sundlöv, Katarina Sjögreen Gleisner, Peter Gjertsson and Peter Bernhardt

Journal of Nuclear Medicine October 1, 2019, 60 (10) 1406-1413; DOI: https://doi.org/10.2967/jnumed.118.225235
You have access
Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors
Hendrik Bergsma, Kirsten van Lom, Marc H.G.P. Raaijmakers, M. Konijnenberg, B.L. Boen L.R. Kam, Jaap J.M. Teunissen, Wouter W. de Herder, Eric P. Krenning and Dik J. Kwekkeboom

Journal of Nuclear Medicine March 1, 2018, 59 (3) 452-458; DOI: https://doi.org/10.2967/jnumed.117.189712
You have access
NAMPT Inhibitor GMX1778 Enhances the Efficacy of ¹⁷⁷Lu-DOTATATE Treatment of Neuroendocrine Tumors
Anna-Karin Elf, Peter Bernhardt, Tobias Hofving, Yvonne Arvidsson, Eva Forssell-Aronsson, Bo Wängberg, Ola Nilsson and Viktor Johanson

Journal of Nuclear Medicine February 1, 2017, 58 (2) 288-292; DOI: https://doi.org/10.2967/jnumed.116.177584
You have access
Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE
Ezgi Ilan, Mattias Sandström, Cecilia Wassberg, Anders Sundin, Ulrike Garske–Román, Barbro Eriksson, Dan Granberg and Mark Lubberink

Journal of Nuclear Medicine February 1, 2015, 56 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.114.148437

Main menu

User menu

Search

177Lu-DOTATATE